Silvia Montaner

5.2k total citations · 1 hit paper
60 papers, 4.2k citations indexed

About

Silvia Montaner is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Silvia Montaner has authored 60 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Oncology and 19 papers in Ophthalmology. Recurrent topics in Silvia Montaner's work include Viral-associated cancers and disorders (18 papers), Retinal Diseases and Treatments (17 papers) and Lipid metabolism and disorders (13 papers). Silvia Montaner is often cited by papers focused on Viral-associated cancers and disorders (18 papers), Retinal Diseases and Treatments (17 papers) and Lipid metabolism and disorders (13 papers). Silvia Montaner collaborates with scholars based in United States, China and Spain. Silvia Montaner's co-authors include Akrit Sodhi, J. Silvio Gutkind, Juan Carlos Lacal, Rosario Perona, Enrique A. Mesri, Isabel Sánchez‐Pérez, R Bravo, Earl T. Sawai, Tao Ma and Jiadi Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Silvia Montaner

58 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins.

1997 536 citations Rosario Perona, Silvia Montaner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvia Montaner United States	31	1.9k	1.6k	956	803	631	60	4.2k
Akrit Sodhi United States	33	1.7k 0.9×	1.4k 0.9×	740 0.8×	711 0.9×	532 0.8×	64	4.3k
Grazia Ambrosini United States	27	4.8k 2.6×	2.2k 1.4×	743 0.8×	496 0.6×	1.2k 1.9×	48	6.8k
Anna‐Karin Olsson Sweden	28	2.7k 1.4×	1.1k 0.7×	848 0.9×	182 0.2×	1.2k 1.9×	65	4.8k
Masabumi Shibuya Japan	41	4.6k 2.5×	1.7k 1.0×	1.2k 1.2×	223 0.3×	990 1.6×	77	6.6k
Philip H. Howe United States	46	3.7k 2.0×	1.6k 1.0×	1.1k 1.1×	276 0.3×	788 1.2×	104	5.2k
Martin F. Wolfson United States	13	2.0k 1.1×	1.6k 1.0×	1.0k 1.1×	334 0.4×	1.7k 2.7×	19	5.1k
Leigh Coultas Australia	24	4.3k 2.3×	1.3k 0.8×	876 0.9×	339 0.4×	1.1k 1.8×	34	5.9k
P. Linga Reddy India	12	2.0k 1.1×	1.5k 0.9×	1.0k 1.0×	294 0.4×	1.2k 1.9×	13	4.7k
Nader Rahimi United States	38	2.5k 1.3×	746 0.5×	524 0.5×	187 0.2×	497 0.8×	76	3.9k
Prem Seth United States	50	4.5k 2.4×	3.1k 1.9×	967 1.0×	461 0.6×	903 1.4×	140	7.2k

Countries citing papers authored by Silvia Montaner

Since Specialization

Citations

This map shows the geographic impact of Silvia Montaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Montaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Montaner more than expected).

Fields of papers citing papers by Silvia Montaner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Montaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Montaner. The network helps show where Silvia Montaner may publish in the future.

Co-authorship network of co-authors of Silvia Montaner

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Montaner. A scholar is included among the top collaborators of Silvia Montaner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Montaner. Silvia Montaner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharma, Deepti, Yu Qin, Kathleen Jee, et al.. (2024). VEGF inhibition increases expression of HIF-regulated angiogenic genes by the RPE limiting the response of wet AMD eyes to aflibercept. Proceedings of the National Academy of Sciences. 121(46). e2322759121–e2322759121. 7 indexed citations

Jee, Kathleen, Monika Deshpande, Miguel Flores‐Bellver, et al.. (2023). Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice. Journal of Clinical Investigation. 133(13). 16 indexed citations

Babapoor-Farrokhran, Savalan, Yu Qin, Miguel Flores‐Bellver, et al.. (2023). Pathologic vs. protective roles of hypoxia-inducible factor 1 in RPE and photoreceptors in wet vs. dry age-related macular degeneration. Proceedings of the National Academy of Sciences. 120(50). e2302845120–e2302845120. 25 indexed citations

Menon, Deepak, Tao Ma, Ahmed S. Sultan, et al.. (2023). Angiopoietin-like 4 induces head and neck squamous cell carcinoma cell migration through the NRP1/ABL1/PXN pathway. Cellular Signalling. 108. 110697–110697. 5 indexed citations

Qin, Yaowu, Savalan Babapoor-Farrokhran, Monika Deshpande, et al.. (2022). PAI-1 is a vascular cell–specific HIF-2–dependent angiogenic factor that promotes retinal neovascularization in diabetic patients. Science Advances. 8(9). eabm1896–eabm1896. 29 indexed citations

Yu, Qin, Xuan Cao, Kathleen Jee, et al.. (2022). ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization. JCI Insight. 7(13). 9 indexed citations

Zhang, Jing, Yaowu Qin, Miguel Flores‐Bellver, et al.. (2021). HIF-1α and HIF-2α redundantly promote retinal neovascularization in patients with ischemic retinal disease. Journal of Clinical Investigation. 131(12). 53 indexed citations

Sodhi, Akrit, Tao Ma, Deepak Menon, et al.. (2019). Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema. Journal of Clinical Investigation. 129(11). 4593–4608. 71 indexed citations

Hu, Ke, Savalan Babapoor-Farrokhran, Murilo Wendeborn Rodrigues, et al.. (2016). Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget. 7(7). 7816–7828. 119 indexed citations

10.

Hassan, Syed Junaid, Kathleen Jee, Monika Deshpande, et al.. (2015). Hypoxia Inducible Factor-1 Upregulates the Expression of Plasminogen Activator Inhibitor-1 in Retinal Endothelial Cells to Promote their Survival in Proliferative Diabetic Retinopathy Patients. Investigative Ophthalmology & Visual Science. 56(7). 4282–4282. 1 indexed citations

11.

Chaisuparat, Risa, et al.. (2013). Activation of the Akt/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 116(3). 336–342. 12 indexed citations

12.

Hu, Jiadi, Bruno Correia Jham, Tao Ma, et al.. (2011). Angiopoietin-like 4: A novel molecular hallmark in oral Kaposi’s sarcoma. Oral Oncology. 47(5). 371–375. 32 indexed citations

13.

Ma, Tao, Bruno Correia Jham, Jiadi Hu, et al.. (2010). Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma. Proceedings of the National Academy of Sciences. 107(32). 14363–14368. 87 indexed citations

14.

Jham, Bruno Correia & Silvia Montaner. (2010). The Kaposi's sarcoma‐associated herpesvirus G protein‐coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene. Journal of Cellular Biochemistry. 110(1). 1–9. 24 indexed citations

15.

Sodhi, Akrit, Silvia Montaner, Hiroshi Miyazaki, & J. Silvio Gutkind. (2001). MAPK and Akt Act Cooperatively but Independently on Hypoxia Inducible Factor-1α in rasV12 Upregulation of VEGF. Biochemical and Biophysical Research Communications. 287(1). 292–300. 141 indexed citations

16.

Montaner, Silvia, et al.. (1999). Activation of Serum Response Factor by RhoA Is Mediated by the Nuclear Factor-κB and C/EBP Transcription Factors. Journal of Biological Chemistry. 274(13). 8506–8515. 76 indexed citations

17.

Montaner, Silvia, Alice A. Ramos, Rosario Perona, et al.. (1995). Overexpression of PKC zeta in NIH3T3 cells does not induce cell transformation nor tumorigenicity and does not alter NF kappa B activity.. PubMed. 10(11). 2213–20. 20 indexed citations

18.

Montaner, Silvia & Martin T. Schechter. (1995). A year of transformation in HIV/AIDS. The Lancet. 346. S12–S12. 8 indexed citations

19.

Jiménez, Benilde, Luis del Peso, Silvia Montaner, Pilar Esteve, & Juan Carlos Lacal. (1995). Generation of phosphorylcholine as an essential event in the activation of Raf‐1 and MAP‐kinases in growth factors‐induced mitogenic stimulation. Journal of Cellular Biochemistry. 57(1). 141–149. 78 indexed citations

20.

Iborra, J.L., J. L. Guardiola, Silvia Montaner, Manuel Cánovas, & A. Manjón. (1992). 2,3,5-triphenyltetrazolium chloride as a viability assay for immobilized plant cells. Biotechnology Techniques. 6(4). 319–322. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact